CD07805/47 gel Placebo

DRUG2 trials

Sponsors

Galderma R&D

Conditions

ErythemaRosacea

Phase 3

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema of Rosacea

CompletedNCT01789775

Galderma R&DRosacea

Start: 2012-12-31End: 2013-10-31Updated: 2014-10-20

Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema

WithdrawnNCT01882712

Galderma R&DErythema

Updated: 2014-11-06